The Columbia Lab-to-Market (L2M) Accelerator Network serves as a framework to successfully develop, launch, and execute initiatives to help commercialize academic research. Since 2008, Columbia University has founded or co‐founded multiple accelerator programs encompassing medical technologies, clean energy technologies, therapeutics, and digital media, providing resources to foster the development of concepts and companies that have subsequently raised more than $70M in additional funding. The experience building and improving these programs yielded a powerful set of insights and best practices now leveraged through L2M‐ a collective model for providing core infrastructure and resources to programs supporting early stage university teams as they move technologies forward. With core competencies from the Network, participating industry‐specific programs are able to focus on the provision of expertise to scientific teams.
The Network Advantage
The Columbia Lab-to-Market Accelerator Network:
Leverages best practices and provides common processes via a shared cost model to support programs as they catalyze individual accelerator projects
Streamlines critical core functions, such as application management, overlapping educational resources, outreach and marketing support, event planning, and networking opportunities with industry representatives and the investor community.
Preserves each individual accelerator’s industry‐specific expertise and programming while tapping core competencies from the Network.
- Invites collaboration, feedback and questions from other universities, with the goal of creating a forum for sharing information, best practices, and lessons learned.
Cumulative Success Metrics
- 707 applications received
- 328 team through bootcamps
- 153 cash awards totaling over $12M
- Over 40 commercial launches
- Over $120M in external follow-on funding raised by those teams